PUBMED FOR HANDHELDS

Journal Abstract Search


666 related items for PubMed ID: 17472840

  • 1. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA, Levtchenko EN, Wetzels JF.
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P.
    Nephrol Dial Transplant; 1993 Nov; 8(12):1326-32. PubMed ID: 8159300
    [Abstract] [Full Text] [Related]

  • 4. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY, Wu CY, Tsai IJ, Tsau YK.
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [Abstract] [Full Text] [Related]

  • 5. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 6. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K.
    J Nephrol; 2009 Aug; 22(5):610-5. PubMed ID: 19809993
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
    Kashtan C, Melvin T, Kim Y.
    Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
    [Abstract] [Full Text] [Related]

  • 8. Treatment of steroid resistant nephrotic syndrome in children.
    Kari JA, Halawani M.
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):484-7. PubMed ID: 20427873
    [Abstract] [Full Text] [Related]

  • 9. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD, MacLeod R, Rigby E, Clark AG.
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [Abstract] [Full Text] [Related]

  • 10. Cyclophosphamide therapy in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Srivastava RN, Agarwal RK, Choudhry VP, Moudgil A, Bhuyan UN, Sunderam KR.
    Int J Pediatr Nephrol; 1985 Jul; 6(4):245-50. PubMed ID: 4093243
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A.
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F, Ahmad TM, Anwar S.
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [Abstract] [Full Text] [Related]

  • 13. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [Abstract] [Full Text] [Related]

  • 14. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
    Donia AF, Gazareen SH, Ahmed HA, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
    [Abstract] [Full Text] [Related]

  • 15. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G.
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [Abstract] [Full Text] [Related]

  • 16. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
    Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grünfeld JP, Niaudet P.
    Am J Kidney Dis; 2003 Mar; 41(3):550-7. PubMed ID: 12612977
    [Abstract] [Full Text] [Related]

  • 17. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Pediatr Nephrol; 2002 May; 17(5):355-8. PubMed ID: 12042893
    [Abstract] [Full Text] [Related]

  • 18. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L, Böör A, Sasinka M.
    Cas Lek Cesk; 2008 May; 147(1):38-43. PubMed ID: 18323041
    [Abstract] [Full Text] [Related]

  • 19. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
    Gulati S, Prasad N, Sharma RK, Kumar A, Gupta A, Baburaj VP.
    Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
    [Abstract] [Full Text] [Related]

  • 20. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A, El-Husseini A, El-Dahshan K, Sobh M.
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.